# Aspen Notre Dame de Bondeville, Notre Dame de Bondeville, France – FDA Inspections

Source: https://www.keypedia.com/companies/aspen-notre-dame-de-bondeville/194f72ec-2218-470f-bdd4-76cfcd04064d

> Inspection records and compliance data for Aspen Notre Dame de Bondeville in Notre Dame de Bondeville. 8 FDA inspections on record, last inspected November 07, 2025.

---

## Details

- Name: Aspen Notre Dame de Bondeville
- FEI Number: 3002808079
- Address Line 1: 1 rue de l Abbaye
- City: Notre Dame de Bondeville
- Country Name: France
- Address: 1 rue de l Abbaye, Notre Dame de Bondeville, France
- Country: France

## Related Documents

- FDA Inspection 1309944 - Aspen Notre Dame de Bondeville - 2025-11-07 — source: FDA, date: November 7, 2025
- FDA Inspection 1309944 - Aspen Notre Dame de Bondeville - 2025-11-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 7, 2025
- FDA Inspection 1245201 - Aspen Notre Dame de Bondeville - 2024-06-07 — source: FDA, date: June 7, 2024
- FDA Inspection 1174998 - Aspen Notre Dame de Bondeville - 2021-04-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 16, 2021
- FDA Inspection 1058932 - Aspen Notre Dame de Bondeville - 2018-05-31 — classification: No Action Indicated (NAI), source: FDA, date: May 31, 2018
- FDA Inspection 988923 - Aspen Notre Dame de Bondeville - 2016-08-30 — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2016
- FDA Inspection 850923 - Aspen Notre Dame de Bondeville - 2013-09-17 — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2013
- FDA Inspection 749604 - Aspen Notre Dame de Bondeville - 2011-09-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 2, 2011
- FDA Inspection 577591 - Aspen Notre Dame de Bondeville - 2009-03-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 17, 2009

## Related Companies

- [Organon Heist](https://www.keypedia.com/companies/organon-heist/e737764b-560f-483a-be05-cec3a613c7fb)
- [Fresenius Kabi iPSUM Srl](https://www.keypedia.com/companies/fresenius-kabi-ipsum-srl/57155542-2a5d-4530-8d4e-f08876ccf2d5)
- [Zhejiang Yongning Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-yongning-pharmaceutical-co-ltd/70a5bf94-4ed4-42f8-9efe-e4917c7aae66)
- [Baxter Healthcare S.A.](https://www.keypedia.com/companies/baxter-healthcare-sa/027068ec-1edf-444c-aabb-c9da8dbf31f0)
- [Baxter, S.A. De C.V.](https://www.keypedia.com/companies/baxter-sa-de-cv/f8b22a08-81dc-42b5-a63e-55b31afb5428)
- [BAYER PHARMA, AG](https://www.keypedia.com/companies/bayer-pharma-ag/28300a22-c506-4b1a-9052-6fc4e7170384)
- [N.V. Organon (MSD)](https://www.keypedia.com/companies/nv-organon-msd/dc305126-e2d1-4dba-8538-f815391f40a5)
- [Hainan Shuangcheng Pharmaceuticals Co Ltd](https://www.keypedia.com/companies/hainan-shuangcheng-pharmaceuticals-co-ltd/920c7235-0cdd-4c0a-884c-43e1f605c1c6)
- [ONY Biotech, Inc.](https://www.keypedia.com/companies/ony-biotech-inc/a2997e30-1b39-4dea-9fec-a960aafcefd0)
- [GlaxoSmithKline, LLC.](https://www.keypedia.com/companies/glaxosmithkline-llc/7ab59069-93ea-4898-a74a-874992c27286)